A drug from Japan's Fujifilm Holdings Corp. has emerged as a candidate for treating the Ebola virus, which has killed nearly 1,000 people in Africa during a recent outbreak.

The drug--a anti-influenza tablet called favipiravir--was created by a Fujifilm subsidiary, Toyama Chemical Co., and approved by the Japanese Ministry of Health, Labor and Welfare in March.

A...